Adipsin as a novel prognostic biomarker for cardiovascular diseases

被引：1
|
作者：
Askin, Lutfu [1 ]
Askin, Husna Sengul [2 ]
Abus, Sabri [3 ]
Hidayet, Siho [4 ]
机构：
[1] Adiyaman Educ & Res Hosp, Dept Cardiol, TR-2230 Adiyaman, Turkey
[2] Adiyaman Educ & Res Hosp, Dept Infect Dis, Adiyaman, Turkey
[3] Kahta State Hosp, Dept Cardiol, Adiyaman, Turkey
[4] Inonu Univ, Dept Cardiol, Med Fac, Malatya, Turkey
来源：
COR ET VASA | 2022年 / 64卷 / 01期
关键词：
Adipsin; Atherosclerosis; Cardiovascular disease; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; PROMOTING INFLAMMATION; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; INSULIN-RESISTANCE; RISK-FACTORS; HYPERTENSION; ADIPONECTIN; CYCLOPHILIN;
D O I：
10.33678/cor.2021.086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Increased vascular oxidative stress stimulates the secretion of adipokines from adipocytes. Many clinical studies have demonstrated that plasma adipsin levels are successful in predicting ischemic events. Increased adipsin levels are closely related to all-cause death and morbidity. Therefore, adipsin may be a new biomarker for atherosclerosis. In this review, we aimed to emphasize the association of adipsin with cardiovascular diseases (CVDs) and its beneficial role in the therapeutic field of CVDs.
引用
收藏
页码：34 / 37
页数：4
相关论文
共 50 条
  • [41] Thrombopoietin as Biomarker and Mediator of Cardiovascular Damage in Critical Diseases
    Lupia, Enrico
    Goffi, Alberto
    Bosco, Ornella
    Montrucchio, Giuseppe
    MEDIATORS OF INFLAMMATION, 2012, 2012
  • [42] Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases
    Magni, Paolo
    Macchi, Chiara
    Sirtori, Cesare R.
    Romanelli, Massimiliano Marco Corsi
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (10) : 1579 - 1587
  • [43] The potential for the transcriptome to serve as a clinical biomarker for cardiovascular diseases
    Barth, Andreas S.
    Hare, Joshua M.
    CIRCULATION RESEARCH, 2006, 98 (12) : 1459 - 1461
  • [44] Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases
    Aragon-Herrera, Alana
    Feijoo-Bandin, Sandra
    Anido-Varela, Laura
    Morana-Fernandez, Sandra
    Rosello-Lleti, Esther
    Portoles, Manuel
    Tarazon, Estefania
    Gualillo, Oreste
    Ramon Gonzalez-Juanatey, Jose
    Lago, Francisca
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (07):
  • [45] TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
    Bernardi, Stella
    Milani, Daniela
    Fabris, Bruno
    Secchiero, Paola
    Zauli, Giorgio
    CURRENT DRUG TARGETS, 2012, 13 (09) : 1215 - 1221
  • [46] Skin microvascular endothelial function as a biomarker in cardiovascular diseases?
    Marcin Hellmann
    Matthieu Roustit
    Jean-Luc Cracowski
    Pharmacological Reports, 2015, 67 : 803 - 810
  • [47] Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases
    Jiang, Yong
    Wang, Hui-yan
    Cao, Hong-mei
    Wang, Chun-yan
    Zhang, Lei
    Wang, Hao
    Liu, Lei
    Li, Yan
    Cai, Jian-hui
    SCIENTIFIC REPORTS, 2014, 4
  • [48] Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ-secretase inhibitor
    Searfoss, GH
    Jordan, WH
    Calligaro, DO
    Galbreath, EJ
    Schirtzinger, LM
    Berridge, BR
    Gao, H
    Higgins, MA
    May, PC
    Ryan, TP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) : 46107 - 46116
  • [49] Electrophoretic Determination of Trimethylamine (TMA) in Biological Samples as a Novel Potential Biomarker of Cardiovascular Diseases Methodological Approach
    Konop, Marek
    Rybka, Mateusz
    Waraksa, Emilia
    Laskowska, Anna K.
    Nowinski, Artur
    Grzywacz, Tomasz
    Karwowski, Wojciech J.
    Drapala, Adrian
    Klodzinska, Ewa Maria
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (23)
  • [50] Angiotensin II: A novel biomarker in vascular diseases
    Zhou, Qin-Yi
    Pan, Jin-Qian
    Liu, Wang
    Jiang, Zhen-Tao
    Gao, Fang-Ya
    Zhao, Zhen-Wang
    Tang, Chao-Ke
    CLINICA CHIMICA ACTA, 2025, 568
12345